A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer

Clinical trial NCT07766018 · RECRUITING

Trial details

NCT number: NCT07766018
Sponsor: Stemline Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

ER+/HER2- Advanced or Metastatic Breast Cancer

Start date: 2026-08-01
Primary completion: 2028-10-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.